India’s pharma exports, currently valued at nearly $27.8 billion, are expected to cross $30 billion by this year end, Union Minister Dr Jitendra Singh said here on Tuesday.

Singh disclosed that India's domestic pharma market is $60 billion, but is expected to double, that is, $130 billion by 2030.

The remarks come days after US President Donald Trump announced a 100 per cent tariff on branded or patented pharmaceutical products, unless the manufacturer is building a pharmaceutical manufacturing plant in the United States.

Singh was speaking after signing of an MoU between the Department of Biotechnology (DBT), and the Uttar Pradesh government. The agreement, executed through DBT’s Biotechnology Industry Research Assistance Council (BIRAC) and the Uttar Pradesh Promote Pharma Council (UP

See Full Page